Adeno-associated virus: The gene therapy revolution faces manufacturing and safety hurdles Post author: Post published:April 5, 2024 Post category:uncategorized Recombinant adeno-associated virus (rAAV)-based genetic applications to treat human diseases. You Might Also Like Researchers classify how specific genetic mutations correspond to rare disorders July 30, 2025 Apple cider vinegar shows promise in weight loss and metabolic health March 13, 2024 Indiana University scientists pioneer oculomics research with NIH support October 13, 2024